CD31

Source: Wikipedia, the free encyclopedia.
PECAM1
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_000442

NM_001032378
NM_008816
NM_001305157
NM_001305158

RefSeq (protein)

NP_000433

NP_001027550
NP_001292086
NP_001292087
NP_032842

Location (UCSC)Chr 17: 64.32 – 64.41 MbChr 11: 106.55 – 106.64 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Platelet endothelial cell adhesion molecule (PECAM-1) also known as cluster of differentiation 31 (CD31) is a protein that in humans is encoded by the PECAM1 gene found on chromosome17q23.3.[5][6][7][8] PECAM-1 plays a key role in removing aged neutrophils from the body.

Structure

PECAM-1 is a highly glycosylated

Ig-like domains.[10]

Interactions

PECAM-1 is a cell-cell adhesion protein[11] which interacts with other PECAM-1 molecules through homophilic interactions or with non-PECAM-1 molecules through heterophilic interactions.[12] Homophilic interactions between PECAM-1 molecules are mediated by antiparallel interactions between extracellular Ig-like domain 1 and Ig-like domain 2. These interactions are regulated by the level of PECAM-1 expression. Homophilic interactions occur, only when the surface expression of PECAM-1 is high. Otherwise, when expression is low, heterophilic interactions occur.[13]

Tissue distribution

CD31 is normally found on endothelial cells, platelets, macrophages and Kupffer cells, granulocytes, lymphocytes (T cells, B cells, and NK cells), megakaryocytes, and osteoclasts.

Immunohistochemistry

Micrograph of an angiosarcoma stained with a CD31 immunostain (dark brown).

In

lymphoblastic lymphomas, although more specific markers are available for these conditions.[14]

Function

PECAM-1 is found on the surface of

endothelial cells binds to the CD38 receptor on natural killer cells for those cells to attach to the endothelium.[15][16]

Role in signaling

PECAM-1 plays a role in

Leukocyte transmigration

PECAM-1 is involved in migration of

hematopoietic progenitor cells[22] through the endothelial cells. Moreover, PECAM-1 is involved in transendothelial migration of recent thymic emigrants to the secondary lymphoid organs.[23] Mechanism of leukocyte transmigration can be explained by creating a homophilic interaction. In this interaction migrating leukocytes express PECAM-1 on the surface and then they react with PECAM-1 on the surface of endothelial cell.[24]

Angiogenesis

PECAM-1 is also important for angiogenesis because it enables the formation of new blood vessels through the cell-cell adhesion.[25]

Role of CD31 in diseases

Cancer

PECAM-1 is expressed by many

solid tumor cell lines such as hemangioma, angiosarcoma, Kaposi’s sarcoma, breast carcinoma, glioblastoma, colon carcinoma, skin carcinoma and other tumor cell lines.[26] On the surface of these tumor cells PECAM-1 mediates the adhesion to endothelial cells.[27] PECAM-1 modulates tumor growth by the formation of new endothelial cell tubes. In mice, this process can be inhibited using an anti-PECAM-1 antibody.[28]

Recently, it was found out that elderly patients with gastric cancer have high concentration of PECAM-1 in the serum. That suggests that the use of a serum PECAM-1 level can be a good prognostic marker.[29]

Atherosclerosis

Inhibition of PECAM-1 leads to a reduction of atherosclerotic lesions in mice.[30] That means that PECAM-1 is involved in atherosclerosis. The exact mechanism, how PECAM-1 contributes to atherosclerosis is not known, but there are some theories. PECAM-1 can act as a mechanoresponsive molecule. Or the pathogenesis can be caused by the infiltration of leukocytes mediated by PECAM-1. Finally, polymorphisms in the PECAM-1 gene can lead to the progression of atherosclerosis.[31]

Disseminated intravascular coagulation

Extensive microvascular thrombosis and increased microvascular permeability are main characteristics of disseminated intravascular coagulation, a fatal complication of sepsis. Patients with this devastating condition have high levels of PECAM-1 in the serum indicating PECAM-1 as a good diagnostic marker. Moreover, PECAM-1 can protect from the development of disseminated intravascular coagulation by inhibiting macrophage pyroptosis.[32]

Neuroinflammation

PECAM-1 contributes to at least two of the nervous system diseases,

leukocytes, which then infiltrate brain parenchyma and release toxic compounds such as oxygen radicals. Interactions between leukocyte and endothelium are mediated by PECAM-1. High levels of soluble PECAM-1 can be used to diagnose both diseases. Increased PECAM-1 levels indicate damage in the blood brain barrier in patients with multiple sclerosis and high PECAM-1 levels can be used as a short-term prediction of a stroke in patients with cerebral ischaemia.[33]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000261371Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000020717Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: platelet/endothelial cell adhesion molecule".
  6. PMID 1690453
    .
  7. .
  8. .
  9. .
  10. .
  11. .
  12. .
  13. .
  14. .
  15. .
  16. .
  17. .
  18. .
  19. .
  20. .
  21. .
  22. .
  23. .
  24. .
  25. .
  26. .
  27. .
  28. .
  29. .
  30. .
  31. .
  32. .
  33. .

Further reading

External links

This page is based on the copyrighted Wikipedia article: CD31. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy